ReviewJournal of stroke2014
Stroke epidemiology in Thailand.
Review in Journal of stroke, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 1 synthesis or guideline pooled it, 143 citations in OpenAlex.
- Younger age of stroke in low-middle income countries is related to healthcare access and quality.Annals of clinical and translational neurology · 2022Pooled it
- Rise of ischaemic stroke incidence among Muslims during the Ramadan period: a 5-year observational study.Singapore medical journal · 2026Observational
- Prospective Open-Label Safety Study of Edaravone Dexborneol in Filipino Patients With Acute Ischemic Stroke.Brain and behavior · 2026Article
- Comparing RAMA-LVO with other Prehospital Large-Vessel Occlusion Prediction Scales in Suspected Acute Stroke; A Retrospective Cross-sectional Study.Archives of academic emergency medicine · 2026Article
- The efficacy of the simple bypass protocol for chronic cerebral arterial occlusion and moyamoya disease.Chinese neurosurgical journal · 2025Article
- Cardiovascular Risk Factors Involved in Hemorrhagic Transformation After Intravenous Thrombolytic Therapy in Patients with Acute Ischemic Stroke.International journal of molecular sciences · 2025Review
- Article
- Stroke and associated comorbidities in Southeast Asian countries.Neuroprotection (Chichester, England) · 2025Review
- Botulinum toxin type A for the treatment of patients with post-stroke spasticity in Thailand: cost-utility and budget impact analysis.BMJ open · 2025Article
- Screening Performance of Stroke Scale for Mid-Level Personnel (SML) in Detecting Acute Stroke with Large Vessel Occlusion: A Cross-sectional Study.Archives of academic emergency medicine · 2025Article
- Real-Time Telemedical Oversight Improves Prehospital Stroke Metrics: A Five-Year Cohort Study.Archives of academic emergency medicine · 2025Article
- Stroke Epidemiology in Asia.Cerebrovascular diseases extra · 2025Review
- Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation at a tertiary care hospital in Thailand.Exploratory research in clinical and social pharmacy · 2024Article
- Validity and reliability of the functional test for hemiplegic upper Extremity-Thai version.Hong Kong journal of occupational therapy : HKJOT · 2024Article
- Incidence of recurrent ischemic stroke and its associated factors in a tertiary care center in Thailand: a retrospective cohort study.BMC neurology · 2024Article
- A descriptive study of stroke types, risk factors, clinical features, and outcomes in a tertiary hospital in Myanmar.Tropical medicine and health · 2024Article
- Combined impact of elevated C-reactive protein levels and dyslipidemia on stroke: a CHNS prospective cohort study.Frontiers in public health · 2024Article
- Performance comparison of stress hyperglycemia ratio for predicting fatal outcomes in patients with thrombolyzed acute ischemic stroke.PloS one · 2024Article
- Investigating the Relationship Between Clinical Characteristics, Mental Health, and Vascular Function in Minor Ischemic Stroke or Transient Ischemic Attack Patients.Health psychology research · 2024Article
- Stroke in Asia.Cerebrovascular diseases extra · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stroke is a major health burden in Thailand. It is the leading cause of death and long term disability in both men and women. Despite the improvement of healthcare system, the mortality rate of stroke is still increasing during the past 5 years. The incidence of stroke in Thailand is now being studied in a large population based cohort. The prevalence of stroke is estimated to be 1.88% among adults 45 years and older. Stroke is more prevalent in men than in women and the mean age of stroke onset is 65 years. Hypertension, diabetes, dyslipidemia, metabolic syndrome, and atrial fibrillation are major risk factors of stroke in the Thai population. Evolution from predominantly rural to urbanized industrial communities result in the increasing prevalence of these risk factors. Similar to other parts of the world, ischemic stroke is the most common stroke type but the proportion of hemorrhagic stroke is higher when compared to Caucasian populations. Among patients with ischemic stroke, lacunar stroke is most common, accounting for almost half followed by atherosclerotic disease. Intracranial atherosclerosis is also prevalent in Thai population. For acute treatment, intravenous thrombolysis has been used in Thailand for over 20 years. Its cost is reimbursed by the national health care system but its use is still limited. With the introduction of the stroke fast track system, prompt stroke treatment across the country is warranted. Stroke unit is now the standard of care in large regional and provincial hospitals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.